Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

SGN-B6A

Catalog No. T9901A-484 Copy Product Info
🥰Excellent
SGN-B6A is an ADC (antibody-drug conjugate) that targets integrin β-6 (ITGB6) using the human IgG1 monoclonal antibody Sigvotatug, and exhibits cytotoxicity towards various integrin β-6 positive cancer cells through the mitosis inhibitor MMAE.

SGN-B6A

Copy Product Info
🥰Excellent
Catalog No. T9901A-484

SGN-B6A is an ADC (antibody-drug conjugate) that targets integrin β-6 (ITGB6) using the human IgG1 monoclonal antibody Sigvotatug, and exhibits cytotoxicity towards various integrin β-6 positive cancer cells through the mitosis inhibitor MMAE.

SGN-B6A
Pack SizePriceUSA StockGlobal StockQuantity
1 mgInquiryInquiryInquiry
5 mgInquiryInquiryInquiry
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Product Introduction

Bioactivity
Description
SGN-B6A is an ADC (antibody-drug conjugate) that targets integrin β-6 (ITGB6) using the human IgG1 monoclonal antibody Sigvotatug, and exhibits cytotoxicity towards various integrin β-6 positive cancer cells through the mitosis inhibitor MMAE.
Application
FACS
Functional assay
Antibody Type
Monoclonal
FormulationSupplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition.
Endotoxin<1.0 EU/mg
Chemical Properties
Storage & Solubility Information
Storagestore at low temperature | -20°C for 1 year | Shipping with blue ice.

Calculator

  • Dilution Calculator
  • Reconstitution Calculator
Related Tags: buy SGN-B6A | purchase SGN-B6A | SGN-B6A cost | order SGN-B6A